Abstract
Pituitary adenylate cyclase activating polypeptide (PACAP) has been shown to be neuroprotective in retinal ischemia and monosodium L-glutamate (MSG)-induced retinal degeneration. Here we describe how different MSG treatments (1x and 3x application) cause retinal damage and finally lead to the destruction of the entire inner retina and how PACAP attenuates this effect. Newborn rats from both sexes were injected subcutaneously with 2 mg/g bodyweight MSG on postnatal days 1, 5 and 9. The left eye was left intact while we injected 5 µl PACAP38 solution (100 pmol) into the vitreous of the right eye with a Hamilton syringe at the time of (i) the first, (ii) the first two or (iii) all three MSG injections. Histological analysis has shown that the above described MSG treatment caused the entire inner plexiform layer (IPL) to degenerate, and the inner nuclear (INL) and ganglion cell layers (GCL) seemed fused. One time PACAP38 treatment at the first MSG application did not change the degenerative capacity of MSG. However, if animals received PACAP38 into the vitreous of the eye at the first 2 or all 3 times, a substantial protective effect could be observed. The IPL remained well discernible, the INL retained 2–3 cell rows and the number of cells in the GCL was substantially higher than in the MSG-treated retinas, and was not significantly different from that observed in the control tissue. We conclude that (i) 2 or 3 times PACAP treatment attenuates retinal degeneration; (ii) one PACAP treatment does not provide protection against repeated excitotoxic insults, and (iii) repeated application of PACAP under these experimental conditions may lead to a primed state in which further neurotoxic insults are ineffective.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Bagnoli P, M Dal Monte and G Casini (2003) Expression of neuro-peptides and their receptors in the developing retina of mammals.Histol. Histopathol. 18, 1219–1242.
Chambille I and J Serviere (1993) Neurotoxic effect of neonatal injections of monosodium L-glutamate (L-MSG) in the retinal ganglion cell layer of the golden hamster: anatomical and functional consequences on the circadian system.J. Comp. Neurol. 338, 67–82.
Chen Q, JW Olney, PD Lukasiewicz, T Almli and C Romano (1998) Fenamates protect against ischemic and excitotoxic injury in chick embryo retina.Neurosci. Lett. 242, 163–166.
Danysz W and CG Parsons (2002) Neuroprotective potential of ionotropic glutamate receptor antagonists.Neurotoxicity Res. 4, 119–126.
Frechilla D, A Garcia-Osta, S Palacios, E Cenarruzabeitia and J Del Rio (2001) BDNF mediates the neuroprotective effect of PACAP38 on rat cortical neurons.Neuroreport 12, 919–923.
Gábriel R and P Witkovsky (1998) Cholinergic, but not the rod pathway-related glycinergic (AII), amacrine cells contain cal-retinin in the rat retina.Neurosci. Lett. 247, 179–182.
Gábriel R, BS Zhu and C Stranicky (1993) Synaptic contacts of serotonin-like immunoreactive and 5,7-dihydroxytryptamine accumulating neurons in the anuran retina.Neuroscience 54, 1103–1114.
Hamano K, H Kiyama, PC Emson, R Manabe, M Nakauchi and M Tohyama (1990) Localization of two calcium-binding proteins, calbindin (28 kDa) and parvalbumin (12 kDa) in the vertebrate retina.J. Comp. Neurol. 302, 417–424.
Izumi S, T Seki, S Shioda, CJ Zhou, A Arimura and R Koide (2000) Ultrastructural localization of PACAP immunoreactivity in the rat retina.Ann. NYAcad. Sci. 921, 317–320.
Jozsa R, A Somogyvari-Vigh, D Reglodi, T Hollosy and A Arimura (2001) Distribution and daily variations of PACAP in the chicken brain.Peptides 22, 1371–1377.
Koves K, O Kantor, V Vereczki, M Kausz, A Nemeskeri, K Fogel, A Kiss, TJ Gorcs, G Szeiffert and A Atrimura (2000) PACAP and VIP in the photoneuroendocrine system. From the retina to the pituitary gland.Ann. NYAcad. Sci. 921, 321–326.
Kubrusly RC, MC da Cunha, RA Reis, H Soares, AL Ventura, E Kurtenbach, MC de Mello and FC de Mello (2005) Expression of functional receptors and transmitter enzymes in cultured Muller cells.Brain Res. 1038, 141–149.
Mathieu M, M Ciarlo, N Trucco, F Griffero, G Damonte, A Salis and M Vallarino (2004) Pituitary adenylate cyclase activating polypeptide in the brain, spinal cord and sensory organs of the zebrafish,Danio rerio, during development.Dev. Brain Res. 151, 169–185.
Morio H, I Tatsuno, A Hirai, Y Tamura and Y Saitoh (1996) Pituitary adenylate cyclase activating polypeptide protects rat-cultured cortical neurons from glutamate-induced cytotoxicity.Brain Res. 741, 82–88.
Nilsson SF (1994) PACAP-27 and PACAP-38: vascular effects in the eye and some other tissues in the rabbit.Eur. J. Pharmacol. 253, 17–25.
Nilsson SF, P De Neef, P Robberecht and J Christophe (1994) Characterization of ocular receptors for pituitary adenylate cyclase activating polypeptide (PACAP) and their coupling to adenylate cyclase.Exp. Eye Res. 58, 459–467.
Olianas MC, A Ingianni, V Sogos and P Onali (1997) Expression of pituitary adenylate cyclase activating polypeptide (PACAP) receptors and PACAP in human fetal retina.J. Neurochem. 69, 1213–1218.
Onali P and MC Olianas (1994) PACAP is a potent and highly effective stimulator of adenylyl cyclase activity in the retinas of different mammalian species.Brain Res. 641, 132–134.
Osborne NN, M Ugarte, M Chao, G Chidlow, JH Bae, JP Wood and MS Nash (1999) Neuroprotection in relation to retinal ischemia and relevance to glaucoma.Surv. Ophtalmol. 43 Suppl. 1, S102-S128.
Osborne NN, RJ Casson, JP Wood, G Chidlow, M Graham and J Melena (2004) Retinal ischemia: mechanisms of damage and potential therapeutic strategies.Prog. Retin. Eye Res. 23, 91–147.
Paicone LR, MJ Szego, S Ikeda, PM Nishima and RR McInnes (2003) Progress toward understandig the genetic and biochemical mechanisms of inherited photoreceptor degenerations.Ann. Rev. Neurosci. 26, 657–700.
Pedersen V and WJ Schmidt (2000) The neuroprotective properties of glutamate antagonists and antiglutamatergic drugs.Neurotoxicity Res. 2, 179–204.
Rabl K, D Reglodi, T Banvolgyi, A Somogyvari-Vigh, I Lengvari, R Gabriel and A Arimura (2002) PACAP inhibits anoxia-induced changes in physiological responses in horizontal cells in the turtle retina.Regul. Pept. 109, 71–74.
Reglodi D, A Tamas, A Somogyvari-Vigh, Z Szanto, E Kertes, L Lenard, A Arimura and I Lengvari (2002) Effects of pretreatment with PACAP on the infarct size and functional outcome in rat permanent focal cerebral ischemia.Peptides 23, 2227–2234.
Romano C, MT Price and JW Olney (1995) Delayed excitotoxic neurodegeneration induced by excitatory amino acid agonists in isolated retina.J. Neurochem. 65, 59–67.
Samuelsson-Almen M and SF Nilsson (1999) Pituitary adenylate cyclase activating polypeptide- and VIP-induced activation of adenylate cyclase in the porcine non-pigmented ciliary epithelium: effects of antagonists.J. Ocul. Pharmacol. Ther. 15, 389–400.
Seki T, S Shioda, D Ogino Y Nakai, A Arimura and R Koide (1997) Distribution and ultrastructural localization of a receptor for pituitary adenylate cyclase activating polypeptide and its mRNA in the rat retina.Neurosci. Lett. 238, 127–130.
Seki T, S Shioda, S Izumi, A Arimura and R Koide (2000) Electron microscopic observation of pituitary adenylate cyclase activating polypeptide (PACAP)-containing neurons in the rat retina.Peptides 21, 109–113.
Seki T, S Izumi, S Shioda and A Arimura (2003) Pituitary adenylate cyclase activating polypeptide (PACAP) protects against ganglion cell death after cutting of optic nerve in the rat retina.Regul. Pept. 115, 55.
Shoge K, HK Mishima, T Saitoh, K Ishihara, Y Tamura, H Shiomi and M Sasa (1998) Protective effects of vasoactive intestinal peptide against delayed glutamate neurotoxicity in cultured retina.Brain Res. 809, 127–136.
Shoge K, HK Mishima, T Saitoh, K Ishihara, Y Tamura, H Shiomi, and M Sasa (1999) Attenuation by PACAP of glutamate-induced neurotoxicity in cultured retinal neurons.Brain Res. 839, 66–73.
Silveira MS, MR Costa, M Bozza and R Linden (2002) Pituitary adenylate cyclase activating polypeptide prevents induced cell death in retinal tissue through activation of cyclic AMP-dependent protein kinase.J. Biol. Chem. 277, 16075–16080.
Smythies J (1999) The neurotoxicity of glutamate, domapine, iron and reactive oxygen species: functional interrelationships in health and disease: a review - discussion.Neurotoxicity Res. 1, 27–39.
Somogyvari-Vigh A and D Reglodi (2004) Pituitary adenylate cyclase activating polypeptide: a potential neuroprotective peptide. Review.Curr. Pharm. Des. 10, 2861–2889.
Sucher NJ, SA Lipton and EB Dreyer (1997) Molecular basis of glutamate toxicity in retinal ganglion cells.Vision Res. 37, 3483–3493.
Sun Q, VEC Ooi, and SO Chan (2001)N-methyl-D-aspartate-induced excitotoxicity in adult rat retina is antagonized by single systemic injection of MK-801.Exp. Brain Res. 138, 37–45.
Tamas A, R Gabriel, B Racz, V Denes, P Kiss, A Lubics, I Lengvari and D Reglodi (2004) Effects of pituitary adenylate cyclase activating polypeptide in retinal degeneration induced by mono-sodium-glutamate.Neurosci. Lett. 372, 110–113.
Thoreson WB and P Witkovsky (1999) Glutamate receptors and circuits in the vertebrate retina.Prog. Retinal Res. 18, 765–810.
Toriu N, A Akaibe, H Yasuyoshi, S Zhang, S Kashii, Y Honda, M Shimazawa and H Hara (2000) Lomerizine, a Ca2+ channel blocker, reduces glutamate-induced neurotoxicity and ischemia/ reperfusion damage in rat retina.Exp. Eye Res. 70, 475–484.
Tuncel N, H Basmak, K Uzuner, M Tuncel, G Altiokka, V Zaimoglu, A Ozer and F Gurer (1996) Protection of rat retina from ischemia-reperfusion injury by vasoactive intestinal peptide (VIP): the effect of VIP on lipid peroxidation and antioxidant enzyme activity of retina and choroid.Ann. NY Acad. Sci. 805, 489–498.
van Rijn CM, E Marani and WJ Rietveld (1986) The neurotoxic effect of monosodium glutamate (MSG) on the retinal ganglion cells of the albino rat.Histol. Histopathol. 1, 291–295.
Vaudry D, BJ Gonzalez, M Basille, Y Anouar, A Fournier and H Vaudry (1998) Pituitary adenylate cyclase activating polypeptide stimulates both c-fos gene expression and cell survival in rat cerebellar granule neurons through activation of the protein kinase Apathway.Neuroscience 84, 801–812.
Vidal-Sanz M, M Lafuente, P Sobrado-Calvo, I Selles-Navarro, E Rodriguez, S Mayor-Torroglosa and MP Villegas-Perez (2000) Death and neuroprotection of retinal ganglion cells after different types of injury.Neurotoxicity Res. 2, 215–227.
Villani L, A Beraudi, A Guiliani and A Poli (2001) MPTP-induced apoptosis in the retina of goldfish.Neurotoxicity Res. 3, 255–257.
Wang YZ, P Alm and R Hakanson (1995) Distribution and effects of pituitary adenylate cyclase activating peptide in the rabbit eye.Neuroscience 69, 297–308.
Waschek JA (2002) Multiple actions of pituitary adenylyl cyclase activating peptide in nervous system development and regeneration.Dev. Neurosci. 24, 14–23.
Wassle H, U Grunert and J Rohrenbeck (1993) Immunocytochemical staining of AII amacrine cells in the rat retina with antibodies against parvalbumin.J. Comp. Neurol. 322, 407–420.
Yoshitomi T, K Yamaji, H Ishikawa and Y Ohnishi (2002) Effect of pituitary adenylate cyclase activating peptide on isolated rabbit iris sphincter and dilator muscles.Invest. Ophtalmol. Vis. Sci. 43, 780–783.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Babai, N., Atlasz, T., Tamás, A. et al. Degree of damage compensation by various pacap treatments in monosodium glutamate-induced retinal degeneration. neurotox res 8, 227–233 (2005). https://doi.org/10.1007/BF03033976
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF03033976